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In vitro fertilization (IVF) treatment outcomes have continued to improve with the implementation of progressive techniques including the introduction 
of sequential culture media, blastocyst culture, assisted 
hatching and pre-implantation screening; however, 
despite overcoming the barriers to conception, and the 
precise control over so many pre and post conception 
aspects, the global IVF success rates remain reasonably 
static (Beck et al., 2010, Das et al., 2009, Gardner 
and Lane, 1997, Geary, 2006, Handyside et al., 1992, 
Munne et al., 1993, Palermo et al., 1992).  Preterm 
birth also continues to be an increasing global problem, 
which exists in IVF even with the best practice shift 
from multiple embryo transfers to single embryo 
transfers, resulting in a reduction in multiple gestations 
(Beck et al., 2010, Vulliemoz, 2012).  The presence of 
microorganisms within the upper genital tract, and 
those that contaminate the IVF culture system may 
result in poor quality oocytes, poor quality embryos 
(possibly due to oocyte DNA fragmentation), early 
pregnancy loss or preterm birth.
IVF procedures offer a unique opportunity 
for screening biological fluids (ovarian follicular 
fluid, Fallopian tube washings, peritoneal fluid and 
endometrial aspirates) that would not otherwise be 
available due to the invasive nature of the collection 
procedure.  A small number of researchers have 
reported isolating microorganisms from the IVF culture 
system, with mixed reports surrounding the significance 
of such a discovery (Artley et al., 1993, 
Cottell et al., 1996, Pelzer et al., 2011).  The 
microbiota (microorganisms, their genetic elements 
and the environment in which they are living) at each 
of these sites has the potential to be transferred to 
additional sites by iatrogenic procedures involved in the 
IVF cycle (Table I).
do we really believe that the female upper 
genital tract is sterile?
An increasing body of evidence suggests that the 
female upper genital tract is not as sterile as once 
thought (Spence et al., 1982, Viniker, 1999, Pelzer et 
al. unpublished data).  Notably, clinical predictors 
traditionally used for diagnosing an overt infection 
(febrile temperatures, purulent discharge, pain, raised 
white cell counts), are absent even in the presence 
of a diverse range of microorganisms, suggesting 
that the female upper genital tract is at the very least 
transiently colonized in healthy women.  Importantly, 
asymptomatic inflammation of the endometrial 
cavity results in decreased conception rates for both 
natural and IVF cycles (Feghali et al., 2003, Taylor and 
Frydman, 1996).  Is knowledge of the upper genital 
tract microbiome relevant for assisted reproduction 
technology? Can we use our new knowledge of the 
upper genital tract microbiome to explain shortcomings 
in IVF, particularly in couples with idiopathic infertility? 
Can we improve IVF outcomes using appropriate, 
timed, currently available antimicrobial therapy?
What is the anatomical source of the follicular 
fluid microorganisms?
A diverse range of microorganisms have been 
detected in human follicular fluids collected from 
women at the time of trans-vaginal oocyte retrieval, 
from laparoscopically collected peritoneal fluid at 
the time of tubal embryo transfer (Artley et al., 1993, 
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Table I.  Sources of microbial contamination of the IVF culture system and their potential impact, prevention and treatment
Site of IVF 
contamination Source of microorganisms in IVF
Potential IVF 
impact Prevention Treatment
Female partner Male partner
Vagina Endometrium Fallopian tubes
Follicular 
fluid
Semen/
spermatozoa
TVOR needle • •
Contamination 
of the IVF culture 
system
Change 
microbiota
Culture media • • •
Contamination 
of gametes and 
embryos by 
microbes and/
or microbial 
metabolites
Antimicrobials 
included in 
culture media
Alter 
antimicrobials
Gametes • • •
Cell damage ± 
apoptosis caused 
by microbes 
or microbial 
metabolites
Inhibit growth 
of pathogens in 
culture media
Embryo transfer 
catheter • • •
Inoculation of the 
endometrium
Inhibit growth 
of pathogens in 
culture media
Embryos • • • Developmental arrest
Inhibit growth 
of pathogens in 
culture media
Endometrium • • • Endometritis Antimicrobial treatment
Fallopian tubes • •
Retrograde 
infection via the 
endometrium
Antimicrobial 
treatment
Peritoneal cavity • • •
Retrograde 
infection via the 
endometrium and 
Fallopian tubes
Antimicrobial 
treatment
Cottell et al., 1996, Pelzer et al., 2011, Saltes, 1995).  
There remains some controversy around whether 
these microorganisms represent colonization of the 
upper genital tract or merely contamination of the 
ovarian follicular fluid by the vaginal flora at the time 
of puncture for trans-vaginal oocyte aspiration (Cottell 
et al., 1996, Pelzer et al., 2011).  We concluded from 
our data that microorganisms could be present in 
either a concordant or a discordant fashion, similar to 
that reported by Spence et al. (1982) in their study of 
paired cervical and endometrial samples.  In our study, 
microorganisms were defined as concordant if present in 
both the upper genital tract (follicular fluids) and in the 
lower genital tract (vaginal secretions) samples collected 
from the same woman. A discordant microbiota was 
defined as a difference in the microorganisms detected 
at each of these sites, suggesting that the upper and 
the lower genital tract were independently colonized 
by microorganisms. We propose that the discordant 
follicular fluid isolates possibly represent an extension 
of the normal regional flora of the lower genital tract 
and transient flora of the endometrium, resulting in a 
specific colonization pattern within the follicular fluid.  
Further, these species may also represent a continuum 
from the lower genital tract to the upper genital tract.  
Finally, the microorganisms detected in both the 
follicular fluids and the vaginal secretions from the same 
woman may merely represent contaminating species 
transferred into the follicular fluid during the oocyte 
retrieval process.  
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IVF outcomes and follicular fluid 
microorganisms
Data from our recent study suggest that the source 
of the microorganisms is less important than the fact 
that they are present in the follicular fluid in the first 
instance (Pelzer et al., 2011).  In our study, there was 
no relationship between follicular fluid colonization or 
contamination and the cause of infertility.  However, 
the microbial contamination of the IVF culture system 
was associated with an increase in the number of 
embryo discards, a reduced embryo transfer rate and 
a reduced pregnancy rate if women had a history of 
endometriosis.  We reported the same results for 
women who had an infertile male partner, perhaps 
suggesting a compounding role for the abnormal 
inflammatory response documented in the reproductive 
tract of these women, rather than a direct effect from 
the microorganisms (Robertson et al., 2002, Weiss et 
al., 2009).  An earlier study reported a similar finding of 
poor IVF outcomes for women with endometriosis and 
positive IVF cultures but not for women with ovulatory 
dysfunction or infertile male partners (Saltes et al., 
1995).  Differences in the conclusions of these studies 
may reflect the differing sample sizes.  
Microbes may contribute to the inflammatory 
environment and the IVF process may further serve 
to reactivate ‘infections’ in these women or to transfer 
microorganisms from one anatomical site to another 
as previously reported (Baber et al., 1988, Howe et al., 
1988, Yuzpe et al., 1989).  Despite the proposed source 
of the microorganisms, follicular fluid microorganisms 
were associated with both positive and negative IVF 
outcomes (Pelzer et al., 2011).  This is consistent with 
prior reports for bacterial vaginosis, endometritis and 
adverse pregnancy outcomes.
When Propionibacterium spp., Streptococcus spp.  
Actinomyces spp., Staphylococcus spp., Bacteroides 
spp. and Bifidobacterium spp.  were isolated from 
follicular fluids, we observed an increase in adverse 
IVF outcomes including decreased fertilization rates, 
decreased embryo transfer rates, decreased pregnancy 
rates or no pregnancy (failed implantation) which may 
reflect poor quality embryos due to damage by the 
microorganisms themselves, microbial metabolites, or a 
hostile implantation environment.  The presence of high 
numbers of Lactobacillus spp. within follicular fluid 
frequently correlated with positive IVF outcomes.  We 
also observed differences between the microorganisms 
isolated from the left and the right ovarian follicular 
fluids and in the corresponding IVF outcomes for each 
side.  Women diagnosed with ovarian endometriomas 
display a similar trend, suggesting that the separate 
vasculature and anatomy within each side of the pelvis 
is important in pathology (Al-Fozan and Tulandi, 2003, 
Last, 1984, Sznurkowski and Emerich, 2008, Vercellini 
et al., 1998).  We propose that the slower drainage 
of the left ovary might promote the persistence of 
microorganisms at that site.
Persistent growth patterns of follicular fluid 
microorganisms
Many genital tract isolates are capable of forming 
biofilms.  The lactobacilli are particularly successful 
in this regard and the metabolic products that they 
produce (H2O2, lactic acid, peroxidase) create an 
environment that does not favour colonization by other 
species in high numbers (Klebanoff and Coombs, 1991, 
Klebanoff et al., 1991, Martin et al., 1999).  However, 
the lactobacilli co-exist with a diverse range of microbial 
species in the genital tract.
Microorganisms traditionally live either as 
free-floating planktonic cells or as communities 
within biofilms.  By growing as biofilms, they become 
metabolically inactive and develop a protective outer 
coating composed of polysaccharide, nucleic acid, 
mineral and protein capable of inhibiting detection 
and management by the host immune response, 
antimicrobial treatment and chemical disinfection 
(Trinidad, 2010).  We studied the long-term in vitro 
growth of microorganisms isolated from human 
follicular fluid and report that they persist for at least 28 
weeks without the nutrient supplementation or waste 
removal, which would occur in vivo.  Other studies 
have similarly examined the persistence of Gardnerella 
vaginalis, Neisseria gonorrhoeae and lactobacilli 
on genital tract cells.  Some species of lactobacilli 
are capable of disrupting Gardnerella spp. biofilm 
surface area, density and depth (Saunders et al., 2007).  
Gardnerella spp. associated with bacterial vaginosis 
reportedly resists standard treatment with antimicrobial 
agents, promoting the recurrence of infection in 
subsequent menstrual cycles (Swidsinski et al., 2005).  
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Interestingly, pure cultures of Gardnerella vaginalis do 
not always cause bacterial vaginosis, and low numbers 
of this species frequently colonize the female lower 
genital tract (Patterson et al., 2009, Srinivasan et al., 
2010).  In some women, the lower genital microbiota 
frequently reverts to bacterial vaginosis during menses, 
despite repeated treatment and apparent resolution of 
the condition (Srinivasan et al., 2010).  Similar to their 
interaction with Gardnerella spp., some lactobacilli also 
compete with gonococci for attachment to genital tract 
epithelial cells and are capable of reducing gonococcal 
invasion of the epithelial cells (Spurbeck and Arvidson, 
2008, Vielfort et al., 2008). IVF studies have reported 
that the genital tract lactobacilli are stable once estradiol 
levels become elevated (Jakobsson and Forsum, 2008).  
The same species have also been reported as dominant 
isolates in the vaginal flora of women of reproductive 
age (Ravel et al., 2011).  Recent studies confirm that the 
vaginal microbiota changes throughout the menstrual 
cycle because of steroid hormone levels (Hyman et 
al., 2012, Jakobsson and Forsum, 2008, Srinivasan 
et al., 2010).  Some women exhibit a healthy vaginal 
microbiota, which is composed predominantly of 
species thought to be causal in bacterial vaginosis.  Such 
women achieved pregnancies but no data are available 
to assess the impact of these species on a developing 
pregnancy (Ravel et al., 2011).  
Biofilms are associated with any environment where 
there is a liquid-solid interface.  The biofilms may also 
represent a protected form of growth, which can exist 
in a mutualistic relationship (for example with the 
vaginal lactobacilli) when formed within the correct site. 
However, once disrupted, as is the case in trans-vaginal 
oocyte retrieval and possibly to a lesser extent, during 
embryo transfer, then the dormant biofilm cells have 
the potential to translocate to other genital tract sites.  
Once again metabolically active, the microbial cells may 
replicate and cause contamination or overt infection, or 
elicit an inflammatory response by antigenic properties 
of the individual cells or their products of metabolism 
(Kaplan and Fine, 2002, Kaplan, 2010).
There is the potential to alter the genital tract 
microbiota using probiotics and knowledge of the 
hormonal milieu during the menstrual cycle.  It is in 
theory possible to repopulate the genital tract with 
‘good’ endogenous species (Mailander-Sanchez et al., 
2012).  There is evidence to suggest that rectal isolates 
can result in opportunistic infection of the genital 
tract and adverse pregnancy outcomes, and the use of 
gastrointestinal tract normal regional flora as probiotics 
in women undergoing IVF treatment has not proved 
useful in improving IVF outcomes (Gilboa et al., 2005).  
However, studies investigating the protective role of 
lactobacilli in reducing gonococcal infection support 
the notion that to have a beneficial effect, the species 
must originate from the endogenous vaginal lactobacilli 
(Vielfort et al., 2008).  
Antimicrobial prophylaxis
Antimicrobial prophylaxis has attracted research in 
IVF as an important consideration prior to performing 
any invasive procedures.  In our IVF unit, we screen 
couples for the blood borne viruses, Hepatitis B and 
C, and HIV prior to entry into an IVF cycle as per the 
National guidelines for the collection and storage of 
human tissue.  In addition, we also screen (and treat) 
both partners for genital tract infections.   In our study 
to assess whether the cause of infertility or underlying 
pathology was related to variations in the follicular fluid 
or vaginal microbiota, antimicrobial treatment prior 
to trans-vaginal oocyte retrieval or following embryo 
transfer was not required for any women.  A single dose 
of a second-generation cephalosporin was routinely 
administered after anaesthetic induction for trans-
vaginal oocyte retrieval.  
Of note, the majority of bacterial species identified 
within follicular fluids were anaerobes.  We highlight 
that these are generally not targeted by penicillin, 
streptomycin or gentamicin, the antimicrobials routinely 
included in IVF culture media, or the cephalosporins 
used for prophylaxis in gynaecological surgery 
(non-hysterectomy, non-termination of pregnancy).  
Antimicrobial treatment in our IVF clinic was based 
on those prescribed in the Therapeutic guidelines 
(antibiotic), a National reference tool for pharmaceutical 
prescribing in Australia. Antimicrobial sensitivity 
studies were performed using the CDS method (Bell, 
2012, Antibiotic Expert Group, 2010).   We note that 
this regimen may be different in other countries.
Future studies should aim to establish the potential 
for antimicrobial embryotoxicity as well as the minimum 
inhibitory concentrations of alternative antimicrobials 
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that could be added to the IVF culture 
media.  Curtis et al.  (1991) suggested 
that the antibiotics in culture media 
might not actually reach a therapeutic 
range.  We propose that couples who 
have repeated IVF failures and whose 
samples (follicular fluids, vaginal 
swabs, washed semen, IVF culture 
media) have been screened for the 
presence of, and shown to harbour 
microorganisms resistant to those 
routinely employed in the IVF culture 
system and treatment cycle, might 
benefit from such a change.
The aim throughout the IVF cycle 
should be to promote the growth of 
a normal regional flora within the 
genital tract and the gastrointestinal 
tract.  Antimicrobial therapy 
during an IVF cycle may actually be 
detrimental to the IVF outcomes by 
altering the normal microbiota in 
the genital tract (Huyser et al., 1991, 
Liversedge et al., 1996).  Studies 
investigating the treatment of both 
partners concluded that there was 
no advantage of treatment in the 
absence of infection; rather the results 
were likely to be detrimental to the 
cycle outcomes (Gallegos et al., 2008, 
Liversedge et al., 1996).  
Hormone dependent microbial 
growth patterns and the 
menstrual cycle
A close relationship exists between 
the regulation of microbial growth 
in the female genital tract and 
the menstrual cycle.  Reports of 
genital tract infections occur in a 
cycle-dependent fashion (Reviewed 
by Sonnex, 1998), attributed to 
changes in the secretion levels of 
the steroid hormones estradiol 
and progesterone and the ability of 
some microbial species to use these 
Figure 1.   
Just prior to ovulation, dampening down of all aspects of the female 
the immune response occurs in preparation for genital tract priming 
by the seminal fluid, followed by fertilization, implantation and 
pregnancy. The relationship between the menstrual cycle steroid 
hormones, estradiol and progesterone, and genital tract infection 
diagnoses is illustrated. The menstrual and proliferative phases of the 
menstrual cycle demonstrate the greatest alterations in the genital 
tract microbiota. Thus, diagnosis of the majority of female genital tract 
infections also occurs in the first half of the cycle.
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hormones as growth factors (Kornman and Loesche, 
1982).  The Lactobacillus spp.  concentration is highest 
when estradiol levels are high, and the concentration 
of opportunistic pathogens reportedly increases 
during menstruation (Figure 1).  Subsequent changes 
in the composition of the genital tract epithelium, 
the secretion of mucous and the localized immune 
response, follow the pattern of the hormonal changes 
(Brabin, 2001, Ceruti et al., 1994, McGregor et al., 1990, 
Sonnex, 1998).  In women undergoing IVF cycles, the 
hormone levels of the steroid hormones estradiol and 
progesterone are reportedly eight and three fold higher 
respectively than in normal cycling women (Kushnir et 
al., 2009).
The steroid hormones also contribute to the 
physiological function of the genital tract.  For example, 
the vaginal epithelial thickness, parakeratosis and 
glycogen content rise at mid-cycle (Nauth and Haas, 
1985).  The cervico-vaginal secretions become thicker, 
clearer and more elastic around the time of ovulation 
(Farage and Maibach, 2006).   The endometrium 
undergoes significant remodelling throughout the cycle 
with secretory cells swelling to produce cytoplasmic 
projections and changes in the microvilli and an 
increase in secretory granules in the ovulatory stage 
(Hayashidani and Fujiwara, 1986).  In the Fallopian tube, 
estradiol stimulates epithelial cell hypertrophy, secretion 
and ciliogenesis, whilst high levels of progesterone 
promote atrophy and deciliation (Donnez et al., 1985, 
Verhage et al., 1979).   Ciliary beat frequency also 
changes throughout the menstrual cycle (Lyons, 2006).  
Remodelling of the ovary occurs throughout the cycle 
to produce the dominant follicle and then the corpus 
luteum.  It is therefore likely that the microbial growth 
patterns, and the changes in the genital tract epithelium 
and secretions that occur in response to the secretion 
of the menstrual cycle steroid hormones, combine to 
determine the microbiota detected at each genital tract 
site.  It would be interesting to examine changes in the 
genital tract microbiota of women using luteal support 
following embryo transfer to determine the impact of 
the hormonal changes observed in natural cycles, fully 
stimulated cycles and hormone replacement therapy 
cycles.
In addition to the ovarian follicular fluid aspirates, 
microorganisms can also be recovered from the 
peritoneal fluids of women undergoing assisted 
reproduction, from Fallopian tube washings following 
falloposcopy, from the endometrium of women with 
and without a history of bacterial vaginosis and from 
pre-term placentas delivered vaginally or by Caesarean 
section (Cottell et al., 1996, DiGiulio et al., 2010a, 
DiGiulio et al., 2010b, Korn et al., 1995, Onderdonk et 
al., 2008a, Onderdonk et al., 2008b, Pelzer et al., 2011, 
Saltes, 1995).  The lactobacilli are among those species 
frequently identified from each of these upper genital 
tract sites.  Lactobacilli are often difficult to isolate but 
can be recovered from clinical samples in the presence 
and absence of upper genital tract infection and in 
placentas delivered at term or preterm (Andrews et 
al., 2005, Debattista et al., 2004, DiGiulio et al., 2010a, 
DiGiulio et al., 2010b, Korn et al., 1995, Onderdonk 
et al., 2008a, Onderdonk et al., 2008b, Srinivasan 
et al., 2010).  Changes occur in the lactobacillus 
concentration in response to antibiotic treatment, 
but remain reasonably constant throughout the cycle 
in normal cycling women and in those undergoing 
ovarian stimulation cycles for IVF (Jakobsson and 
Forsum, 2008, Srinivasan et al., 2010).  Therefore, 
fluctuations in the numbers of opportunistic pathogens 
comprising the microbiota at these sites may be a more 
relevant indicator for predicting adverse outcomes 
including poor fertilization, poor embryo quality, failed 
implantation and early pregnancy loss.  
The immune response and reproductive health
Several studies have reported correlations between 
cytokines and IVF outcomes.  Indeed, it would appear 
that some might serve as useful predictors of IVF 
outcomes and even the cause of infertility (Fasciani et 
al., 2000, Van Blerkom et al., 1997).  What is apparent 
from the literature is that an accurate determination of 
the concentration of the genital tract cytokines cannot 
occur by measuring those in the systemic circulation.  In 
addition to the systemic cues, the genital tract cytokines 
are synthesised within each tissue in response to local 
stimuli (Dunbar et al., 2012, Ochiel et al., 2008, Wira et 
al., 2005).  It would appear that the immune response 
skew to either pro-inflammatory or anti-inflammatory 
at the correct time in the cycle is essential to ensure 
that each process (menstruation, ovulation, fertilization, 
implantation, placentation and ongoing pregnancy) 
succeeds.  
In our study, the cytokine responses were 
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independent of the microbiota isolated from both the 
follicular fluids and the vaginal secretions using direct 
culture techniques.  That is, we failed to identify any 
correlation between the cytokines reported within the 
follicular fluids or vaginal secretions from women with 
both concordant or discordant upper and lower genital 
tract microbiota (Pelzer et al., 2011).  Therefore, we 
suggest that the microbial isolates in ovarian follicular 
fluids do not represent an overt infection but rather 
normal regional flora or contamination.  
Spandorfer et al. (2001) reported alterations in the 
pro-inflammatory cytokines detected in the cervical 
secretions in women with abnormal vaginal flora, but 
they did not report a correlation between the altered 
cytokine response and the IVF outcomes.  This further 
supports the localized role of the immune mediators.  
In our study, we did correlate the cytokine expression 
with the cause of infertility and the IVF outcomes 
for couples with idiopathic infertility.  It is now also 
apparent that subtle changes in the genes that regulate 
the immune response can influence the infection related 
sequelae (Genc and Onderdonk, 2011, Witkin et al., 
2000).   Site-specific screening of immune markers may 
be useful in couples with repeated IVF failures.  In the 
future, we may also see a shift towards genetic screening 
in such couples.
Screening recommendations to identify genital 
tract pathogens
Based on our current knowledge, screening for 
reproductive infections should occur at the correct 
stage of the menstrual cycle in the female partner to 
maximise isolation of the microorganism.  It would 
be interesting to examine the microbiota in women 
with repeated IVF failures as a function of the type of 
ovarian stimulation cycle, to gain an understanding of 
the changes in the microbiota that might be induced 
by differences in the hormonal profile.  Our samples 
were collected from women undergoing ‘boost’ cycles 
without antibiotic cover and so the microbiota may well 
be different from that observed in other clinics with 
alternative hormonal stimulation protocols as well as 
methods for vaginal preparation prior to trans-vaginal 
oocyte retrieval and antibiotic coverage prior to oocyte 
retrieval and throughout the treatment cycle.  Screening 
of the vaginal and/or gastrointestinal microbiota may 
offer and opportunity for non-invasive treatment of 
infertile women or women with a history of repeated 
spontaneous abortion prior to commencement of IVF.
Recommendations and conclusions in the IVF 
setting
Metagenomic analyses performed as part of the 
human microbiome project have shed light on the vast 
Changes 
to culture 
techniques
Ø	Add rapid media changes to dilute microorganisms out of culture media
Ø	Freeze all embryos in couples with repeated IVF failures and contaminated samples to 
allow antimicrobial treatment of the female partner prior to embryo transfer
Ø	Perform antimicrobial sensitivity assays on pathogens isolated from clinical samples
Ø	Determine minimum inhibitory concentrations for antibiotics in culture media
Ø	Identify alternate antimicrobials and assess embryotoxicity
Screening of 
patient samples
Ø	Determine the most appropriate samples to screen
Ø	Determine the microbiota present in each sample
Ø	Determine the immune system response by measuring cytokines and chemokines in 
clinical samples
Ø	Probiotic treatment to restore normal genital tract microbiota
Ø	Antimicrobial treatment for couples prior to oocyte retrieval or embryo transfer if 
repeated failed cycles and microorganisms consistently isolated from samples
Further research Ø	Determine the impact of media changes and antimicrobials on gametes and embryos
Ø	Identify and characterize the microbial species that are pathogenic at each stage of IVF
Ø	Determine the role of the host immune response in adverse outcomes where pathogens 
are identified
Table II.  Recommendations for reducing the impact of microorganisms on the IVF culture system
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differences in the vaginal microbiota (Hyman et al., 
2012, Ravel et al., 2011, Srinivasan et al., 2010).  It is 
likely that the impact of microorganisms on IVF will 
need to be assessed on a case-by-case basis, rather 
than a one size fits all approach.  We anticipate that 
the microbial screening of the IVF culture system will 
be most useful for couples with idiopathic infertility or 
repeated adverse IVF outcomes.
Microorganisms within the upper genital tract appear 
to be the norm, rather than the exception, despite the 
central dogma that the sterile upper genital tract is 
separated from the non-sterile lower genital tract by the 
cervix and cervical mucus plug.  Women undergoing 
IVF are exposed to frequent iatrogenic procedures  
which can disrupt the surface microbiota including 
vaginal ultrasound scans, trans-vaginal oocyte retrieval 
and embryo transfer.  These procedures rarely result in 
overt infection; however, they do have the potential to 
result in localized inflammation and inoculation of the 
IVF culture system with potential pathogens (Bennett, 
1993, Bergh, 1992, Dicker, 1993, Tureck, 1993).  It would 
appear that systemic antimicrobial treatment in most 
cases would be unnecessary and even detrimental to the 
IVF cycle, simply serving to enhance the possibility of 
opportunistic infection in either the male partner or the 
female partner.  The over-prescription of antimicrobials 
may also create an environmental pressure leading to 
selection for resistant microorganisms.  Microorganisms 
easily contaminate the IVF culture system.  We propose 
three major areas for consideration in reducing the 
impact of microbial contamination on the IVF culture 
system: (1) changes to IVF culture techniques, (2) 
screening of patient samples collected during IVF 
treatment cycles, and (3) further research (Table II).  
Further research should focus on reducing the impact of 
these microorganisms in couples where there is no other 
explanation for IVF failure.  n
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